Avelumab for Patients Previously Treated with Rituximab-Based Chemotherapy
Español  |  中國傳統的  |  简体中文
Call us  (855) 528-7322
Main Menu

Avelumab for Patients Previously Treated with Rituximab-Based Chemotherapy

Sponsor: Pfizer

A three arm study of immunotherapy regimens containing avelumab and utomilumab for patients with Diffuse Large B-Cell Lymphoma that is relapsed or refractory to previous rituximab containing chemotherapy.